Clinical trial

The Predictive Biomarkers in Patients With Locally Advanced Non-small Cell Lung Cancer

NCT06287320

Study summary

ClinicalTrials.gov

The Predictive Biomarkers in Patients With Locally Advanced Non-small Cell Lung Cancer

Design: OBSERVATIONAL · Status: UNKNOWN · Phase: Not specified

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

RADIATION · Unmapped registry intervention concurrent or sequential chemoradiotherapy Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Immunotherapy Find medicine records · Find other trials using this name

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2024-03-01

PhaseN/A

Conditions

Locally Advanced Non-small Cell Lung Cancerunresolved

Interventions

concurrent or sequential chemoradiotherapyRADIATION

ImmunotherapyDRUG

Sponsors & collaborators

Cancer Institute and Hospital, Chinese Academy of Medical Scienceslead sponsor

Mapped research locations

BeijingBeijing Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06287320 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.